Researchers in the U.K. have identified new genetic insights into the leading cause of chronic back pain. A study published in Communications Biology reveals that changes in gene activity trigger the breakdown of spinal shock absorbers, leading to abnormal mineral buildup and spinal hardening. This condition, known as intervertebral disc degeneration, is a major contributor to long-term mobility issues for millions of people.
Scientists from the Universities of Edinburgh and Bristol used zebrafish models to observe how genetic faults mimic human disc disease. They discovered that spinal fusion occurs after the structural scaffold of the spine begins to break down. By monitoring gene activity in these fish, the team identified specific disruptions in fat metabolism and phosphate handling that precede the hardening process.
These findings represent a shift in how medical professionals approach back pain. Currently, surgery is the standard intervention for advanced disc degeneration. However, the study indicates that existing treatments such as bisphosphonates, which are common in osteoporosis care, might prevent or slow the mineral buildup responsible for spinal fusion.
Dietary adjustments also showed promise in the study, as restricting food intake appeared to reduce the incidence of spinal hardening in the research subjects. These results open the door for targeted pharmaceutical interventions that address the biological roots of back pain rather than just the physical symptoms.
Dr. Erika Kague of the University of Edinburgh noted that this research changes the perspective on a condition that has historically relied solely on invasive procedures. While further clinical trials are necessary, the identification of these metabolic pathways provides a new direction for researchers aiming to reduce the burden of spinal disease on the population.